BRIEF-CERo Therapeutics Advances Phase 1 CER-1236 Trial with Dose Intensification in AML

Reuters
Sep 08
BRIEF-CERo <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Advances Phase 1 CER-1236 Trial with Dose Intensification in AML

Sept 8 (Reuters) - CERo Therapeutics Holdings Inc CERO.O:

  • CERO THERAPEUTICS ANNOUNCES DOSE INTENSIFICATION IN PHASE 1 STUDY OF CER-1236 IN ACUTE MYELOID LEUKEMIA

Source text: ID:nGNX7fS7Lc

Further company coverage: CERO.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10